PAR 3.45% 28.0¢ paradigm biopharmaceuticals limited..

Ann: 2023 Annual Report and Appendix 4E, page-10

  1. 278 Posts.
    lightbulb Created with Sketch. 107
    I’m happy to be corrected, but as I understand it Cartrophen is pretty much identical to what we have, although not approved for human use. I doubt therefore that they’ll be any revenue at all from treating pooches.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
28.0¢
Change
-0.010(3.45%)
Mkt cap ! $97.94M
Open High Low Value Volume
30.0¢ 31.5¢ 27.5¢ $444.5K 1.482M

Buyers (Bids)

No. Vol. Price($)
1 19907 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
28.5¢ 3330 1
View Market Depth
Last trade - 16.10pm 02/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.